Copyright
©The Author(s) 2000.
World J Gastroenterol. Feb 15, 2000; 6(1): 61-65
Published online Feb 15, 2000. doi: 10.3748/wjg.v6.i1.61
Published online Feb 15, 2000. doi: 10.3748/wjg.v6.i1.61
Table 1 Relationship between clinicopathological characteristics a nd recurrence or metastasis of HCC
| Parameter | n | Recurrence of metastasis | |
| Yes | No | ||
| Tumor size (cm) | |||
| ≤5 cm | 29 | 10 | 19 |
| >5 cm | 27 | 12 | 15 |
| Liver cirrhosis | |||
| Absent | 8 | 3 | 5 |
| Present | 48 | 19 | 29 |
| Tumor differentiation | |||
| Well | 12 | 4 | 8 |
| Moderate | 23 | 8 | 15 |
| Poor | 9 | 5 | 4 |
| Not determined | 12 | 5 | 7 |
| Clinical staging | |||
| Stage I | 2 | 1 | 1 |
| Stage II | 33 | 10 | 23 |
| Stage III | 18 | 8 | 10 |
| Stage IV | 3 | 3 | 0 |
- Citation: Jiang YF, Yang ZH, Hu JQ. Recurrence or metastasis of HCC: predictors, early detection and experimental antiangiogenic therapy. World J Gastroenterol 2000; 6(1): 61-65
- URL: https://www.wjgnet.com/1007-9327/full/v6/i1/61.htm
- DOI: https://dx.doi.org/10.3748/wjg.v6.i1.61
